Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02783274 · ClinicalTrials.gov registry record · NA

Actis Total Hip System 2 Year Follow-up

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by DePuy Orthopaedics.

Completed
Registry status
NA
Development phase
266
Enrollment target
9
Study locations

NCT02783274 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 266 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02783274, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by DePuy Orthopaedics.

COMPLETED
Registry status
NA
Development phase
266 participants
Enrollment target
9
Study locations

Study Summary

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

Interventions

  • DEVICE Actis Total Hip System

Study Locations (9)

Kentucky

  • - Louisville

Massachusetts

  • - Boston

Minnesota

  • - Rochester

New Hampshire

  • - Lebanon

New York

  • - New York

North Carolina

  • - Charlotte

Pennsylvania

  • - Philadelphia

Texas

  • - Austin

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2016-07-01
Est. Completion 2024-03-13
Phase NA

Sponsor

DePuy Orthopaedics

38 total trials

What the Registry Record Tells You About NCT02783274

The ClinicalTrials.gov registry entry for NCT02783274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Actis Total Hip System is the first listed.

NCT02783274 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Kentucky, Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT02783274 about?

NCT02783274 is a clinical study titled "Actis Total Hip System 2 Year Follow-up". Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and dev...

What is the current status of trial NCT02783274?

This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2016-07-01. Estimated completion is 2024-03-13.

What conditions does trial NCT02783274 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Traumatic Arthritis, Avascular Necrosis of the Femoral Head, Congenital Hip Dysplasia.

What interventions are being tested in trial NCT02783274?

The interventions under investigation include: Actis Total Hip System (DEVICE).

Who is sponsoring clinical trial NCT02783274?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02783274 being conducted?

This trial has 9 study locations across Kentucky, Massachusetts, Minnesota, New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.